Patient Guide: TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected Participants

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 31 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT00980538
Status: ACTIVE_NOT_RECRUITING
Condition: HIV Infections, HIV-1
Phase: PHASE3

Where You Can Participate

This study is available at 31 locations across the country.

Top locations include:
  • • Los Angeles, California
  • • Washington, District of Columbia
  • • New York, New York
  • • And 28 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected Participants - Join Clinical Trial NCTNCT00980538

How to Join This Clinical Trial - NCTNCT00980538

Learn how to participate in this PHASE3 trial studying an investigational therapy for HIV Infections, HIV-1. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with HIV Infections, HIV-1. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
HIV Infections, HIV-1
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT00980538 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 31 locations. Find a study site near you:

Clinical Research Site

Los Angeles, California - United States

Status: Contact for availability

Clinical Research Site

Washington, District of Columbia - United States

Status: Contact for availability

Clinical Research Site

New York, New York - United States

Status: Contact for availability

Clinical Research Site

Philadelphia, Pennsylvania - United States

Status: Contact for availability

Clinical Research Site

Buenos Aires, - Argentina

Status: Contact for availability

Clinical Research Site

Ciudad Autonoma De Buenos Aire, - Argentina

Status: Contact for availability

Clinical Research Site

Belo Horizonte, - Brazil

Status: Contact for availability

Clinical Research Site

Ribeirao Preto, - Brazil

Status: Contact for availability

Clinical Research Site

Rio de Janeiro, - Brazil

Status: Contact for availability

Clinical Research Site

Montreal, Quebec - Canada

Status: Contact for availability

And 21 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for HIV Infections, HIV-1:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships